{"id":2961,"date":"2024-05-03T15:51:28","date_gmt":"2024-05-03T15:51:28","guid":{"rendered":"https:\/\/avaeh.org\/web_nueva_2021\/?p=2961"},"modified":"2024-05-03T15:51:29","modified_gmt":"2024-05-03T15:51:29","slug":"el-farmaco-contra-la-lepra-clofazimina-reduce-la-toxicidad-de-poliq-mediante-la-activacion-de-ppar%ce%b3","status":"publish","type":"post","link":"https:\/\/avaeh.org\/web_nueva_2021\/2024\/05\/03\/el-farmaco-contra-la-lepra-clofazimina-reduce-la-toxicidad-de-poliq-mediante-la-activacion-de-ppar%ce%b3\/","title":{"rendered":"El f\u00e1rmaco contra la lepra clofazimina reduce la toxicidad de poliQ mediante la activaci\u00f3n de PPAR\u03b3"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">\u00abSe llev\u00f3 a cabo una evaluaci\u00f3n qu\u00edmica de alto rendimiento para identificar f\u00e1rmacos que reducen la toxicidad de una prote\u00edna que contiene el primer ex\u00f3n de la prote\u00ednahuntingtina (HTT) de la enfermedad de Huntington (EH) que alberga 94 glutaminas (Htt-Q\u00a0<sub>94<\/sub>\u00a0). Los f\u00e1rmacos candidatos se probaron en una amplia gama de modelos de toxicidad poliQ in vitro e in vivo.\u00bb<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2352396424001592\" target=\"_blank\" rel=\"noreferrer noopener\">LINK ART\u00cdCULO COMPLETO<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00abSe llev\u00f3 a cabo una evaluaci\u00f3n qu\u00edmica de alto rendimiento para identificar f\u00e1rmacos que reducen la toxicidad de una prote\u00edna que contiene el primer ex\u00f3n de la prote\u00ednahuntingtina (HTT) de la enfermedad de Huntington (EH) que alberga 94 glutaminas (Htt-Q\u00a094\u00a0). Los f\u00e1rmacos candidatos se probaron en una amplia gama de [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7,6,4,9,5,58,784,8],"class_list":["post-2961","post","type-post","status-publish","format-standard","hentry","category-sin-categoria","tag-asociacion-valenciana-de-enfermedad-de-huntington","tag-avaeh","tag-enfermedad-de-huntington","tag-enfermedades-raras","tag-huntingtons-disease","tag-neurodegenerativa","tag-polyq","tag-rare-diseases"],"_links":{"self":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/2961","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/comments?post=2961"}],"version-history":[{"count":1,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/2961\/revisions"}],"predecessor-version":[{"id":2962,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/2961\/revisions\/2962"}],"wp:attachment":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/media?parent=2961"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/categories?post=2961"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/tags?post=2961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}